Alchemab has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of patient antibody repertoires. The platform uses well-defined patient samples, deep B cell sequencing, and computational analysis to identify convergent protective antibody responses among individuals that are susceptible but resilient to specific diseases.
Alchemab is building a broad pipeline of protective therapeutics for hard-to-treat diseases, with an initial focus on neurodegenerative conditions and oncology. The highly specialized patient samples that power Alchemab’s platform are made available through valued partnerships and collaborations with patient representative groups, biobanks, industry partners, and academic institutions.
The Role This role will be focussed on applying and developing state of the art science to produce and characterise disease...
The Role We are seeking a talented and creative Bioinformatician with a passion for using computational advances to improve every step...
The Role The Scientist will be based at our laboratories at Whittlesford, responsible for running and developing our high-throughput target screening...
Share
Facebook
X
LinkedIn
Telegram
Tumblr
Whatsapp
VK
Mail